Articles

• • E Maioli and
  • V Fortino

  Protein kinase C: a target for anticancer drugs?

  Endocr Relat Cancer 11 (2) 161-2, doi:10.1677/erc.0.0110161
  • Full Text (PDF)
• Select this article
  • T P Conrads,
  • V A Fusaro,
  • S Ross,
  • D Johann,
  • V Rajapakse,
  • B A Hitt,
  • S M Steinberg,
  • E C Kohn,
  • D A Fishman,
  • G Whitely,
  • J C Barrett,
  • L A Liotta,
  • E F Petricoin, 3rd,
  • and T D Veenstra

  High-resolution serum proteomic features for ovarian cancer detection.

  Endocr Relat Cancer 11 (2) 163-78, doi:10.1677/erc.0.0110163
  • Abstract
  • Full Text (PDF)
• Select this article
  • P E L√∏nning

  Aromatase inhibitors in breast cancer.

  Endocr Relat Cancer 11 (2) 179-89, doi:10.1677/erc.0.0110179
  • Abstract
  • Full Text (PDF)
• Select this article
  • R M O'Regan and
  • F R Khuri

  Farnesyl transferase inhibitors: the next targeted therapies for breast cancer?

  Endocr Relat Cancer 11 (2) 191-205, doi:10.1677/erc.0.0110191
  • Abstract
  • Full Text (PDF)
• Select this article
  • Janet E Brown,
  • Helen Neville-Webbe,
  • and Robert E Coleman

  The role of bisphosphonates in breast and prostate cancers.

  Endocr Relat Cancer 11 (2) 207-24, doi:10.1677/erc.0.0110207
  • Abstract
  • Full Text (PDF)
• Select this article
  • P Roy-Burman,
  • H Wu,
  • W C Powell,
  • J Hagenkord,
  • and M B Cohen

  Genetically defined mouse models that mimic natural aspects of human prostate cancer development.

  Endocr Relat Cancer 11 (2) 225-54, doi:10.1677/erc.0.0110225
  • Abstract
  • Full Text (PDF)
• Select this article
  • V L Goodman,
  • G J Brewer,
  • and S D Merajver

  Copper deficiency as an anti-cancer strategy.

  Endocr Relat Cancer 11 (2) 255-63, doi:10.1677/erc.0.0110255
  • Abstract
  • Full Text (PDF)
• Select this article
  • I Bossis,
  • A Voutetakis,
  • T Bei,
  • F Sandrini,
  • K J Griffin,
  • and C A Stratakis

  Protein kinase A and its role in human neoplasia: the Carney complex paradigm.

  Endocr Relat Cancer 11 (2) 265-80, doi:10.1677/erc.0.0110265
  • Abstract
  • Full Text (PDF)
• Select this article
  • I J McEwan

  Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain.

  Endocr Relat Cancer 11 (2) 281-93, doi:10.1677/erc.0.0110281
  • Abstract
  • Full Text (PDF)
• Select this article
  • X-C Wang,
  • S-Y Xu,
  • X-Y Wu,
  • H-D Song,
  • Y-F Mao,
  • H-Y Fan,
  • F Yu,
  • B Mou,
  • Y-Y Gu,
  • L-Q Xu,
  • X-O Zhou,
  • Z Chen,
  • J-L Chen,
  • and R-M Hu

  Gene expression profiling in human insulinoma tissue: genes involved in the insulin secretion pathway and cloning of novel full-length cDNAs.

  Endocr Relat Cancer 11 (2) 295-303, doi:10.1677/erc.0.0110295
  • Abstract
  • Full Text (PDF)
• Select this article
  • A O Mueck and
  • H Seeger

  Hormone therapy after endometrial cancer.

  Endocr Relat Cancer 11 (2) 305-14, doi:10.1677/erc.0.0110305
  • Abstract
  • Full Text (PDF)
• Select this article
  • I Rzepka-G√≥rska,
  • A Chudecka-G≈Çaz,
  • and B Kosmowska

  FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.

  Endocr Relat Cancer 11 (2) 315-21, doi:10.1677/erc.0.0110315
  • Abstract
  • Full Text (PDF)
• Select this article
  • C Orlando,
  • C Casini Raggi,
  • S Bianchi,
  • V Distante,
  • L Simi,
  • V Vezzosi,
  • S Gelmini,
  • P Pinzani,
  • M Cameron Smith,
  • A Buonamano,
  • E Lazzeri,
  • M Pazzagli,
  • L Cataliotti,
  • M Maggi,
  • and M Serio

  Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue.

  Endocr Relat Cancer 11 (2) 323-32, doi:10.1677/erc.0.0110323
  • Abstract
  • Full Text (PDF)
• Select this article
  • M Theodoropoulou,
  • I Cavallari,
  • L Barzon,
  • D M D'Agostino,
  • T Ferro,
  • T Arzberger,
  • Y Gr√ºbler,
  • L Schaaf,
  • M Losa,
  • F Fallo,
  • V Ciminale,
  • G K Stalla,
  • and U Pagotto

  Differential expression of menin in sporadic pituitary adenomas.

  Endocr Relat Cancer 11 (2) 333-44, doi:10.1677/erc.0.0110333
  • Abstract
  • Full Text (PDF)
• Select this article
  • Jos√© I Botella-Carretero,
  • Manuel G√≥mez-Bueno,
  • Vivencio Barrios,
  • Carmen Caballero,
  • Rafael Garc√≠a-Robles,
  • Jos√© Sancho,
  • and H√©ctor F Escobar-Morreale

  Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.

  Endocr Relat Cancer 11 (2) 345-56, doi:10.1677/erc.0.0110345
  • Abstract
  • Full Text (PDF)
• Select this article
  • S I Ismailov and
  • N R Piulatova

  Postoperative calcitonin study in medullary thyroid carcinoma.

  Endocr Relat Cancer 11 (2) 357-63, doi:10.1677/erc.0.0110357
  • Abstract
  • Full Text (PDF)
• Select this article
  • Maria Trovato,
  • Alessandra Ulivieri,
  • Roberto Dominici,
  • Rosaria Maddalena Ruggeri,
  • Enrica Vitarelli,
  • Salvatore Benvenga,
  • Gaetano Barresi,
  • Francesco Trimarchi,
  • Ercole Brunetti,
  • Aldo Vecchione,
  • Mario Andreoli,
  • and Salvatore Sciacchitano

  Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions.

  Endocr Relat Cancer 11 (2) 365-76, doi:10.1677/erc.0.0110365
  • Abstract
  • Full Text (PDF)
• Select this article
  • B Zierhut,
  • K Mechtler,
  • W Gartner,
  • T Daneva,
  • W Base,
  • M Weissel,
  • B Niederle,
  • and L Wagner

  Heat shock protein 70 (Hsp70) subtype expression in neuroendocrine tissue and identification of a neuroendocrine tumour-specific Hsp70 truncation.

  Endocr Relat Cancer 11 (2) 377-89, doi:10.1677/erc.0.0110377
  • Abstract
  • Full Text (PDF)